At 68 weeks, average weight loss was: In the 12mg group, 58.6% of participants lost at least 25% of their body weight and 39.4% lost at least 30%
Eli Lilly, the pharmaceutical company developing retatrutide, has progressed the compound into Phase 3 clinical trials, which are evaluating its efficacy and safety in larger populations across multiple indications, including obesity and type 2 diabetes
Your provider is employed by or contracted with one of these entities based on your location
Every treatment is medically led, carefully planned and delivered with a focus on natural structure, skin health and long-term facial integrity, never short-term fixes
How much weight can Retatrutide help you lose
Marketing copy that promises specific weight loss numbers